781 related articles for article (PubMed ID: 23359500)
1. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
Johnston A; Fritz Y; Dawes SM; Diaconu D; Al-Attar PM; Guzman AM; Chen CS; Fu W; Gudjonsson JE; McCormick TS; Ward NL
J Immunol; 2013 Mar; 190(5):2252-62. PubMed ID: 23359500
[TBL] [Abstract][Full Text] [Related]
2. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
[TBL] [Abstract][Full Text] [Related]
3. Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24.
Wang F; Smith N; Maier L; Xia W; Hammerberg C; Chubb H; Chen C; Riblett M; Johnston A; Gudjonsson JE; Helfrich Y; Kang S; Fisher GJ; Voorhees JJ
Br J Dermatol; 2012 Jul; 167(1):92-102. PubMed ID: 22458549
[TBL] [Abstract][Full Text] [Related]
4. Induction of Alternative Proinflammatory Cytokines Accounts for Sustained Psoriasiform Skin Inflammation in IL-17C+IL-6KO Mice.
Fritz Y; Klenotic PA; Swindell WR; Yin ZQ; Groft SG; Zhang L; Baliwag J; Camhi MI; Diaconu D; Young AB; Foster AM; Johnston A; Gudjonsson JE; McCormick TS; Ward NL
J Invest Dermatol; 2017 Mar; 137(3):696-705. PubMed ID: 27984037
[TBL] [Abstract][Full Text] [Related]
5. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis.
Chiricozzi A; Guttman-Yassky E; Suárez-Fariñas M; Nograles KE; Tian S; Cardinale I; Chimenti S; Krueger JG
J Invest Dermatol; 2011 Mar; 131(3):677-87. PubMed ID: 21085185
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.
Zaba LC; Suárez-Fariñas M; Fuentes-Duculan J; Nograles KE; Guttman-Yassky E; Cardinale I; Lowes MA; Krueger JG
J Allergy Clin Immunol; 2009 Nov; 124(5):1022-10.e1-395. PubMed ID: 19895991
[TBL] [Abstract][Full Text] [Related]
7. Etanercept downregulates the Th17 pathway and decreases the IL-17+/IL-10+ cell ratio in patients with psoriasis vulgaris.
Antiga E; Volpi W; Cardilicchia E; Maggi L; Filì L; Manuelli C; Parronchi P; Fabbri P; Caproni M
J Clin Immunol; 2012 Dec; 32(6):1221-32. PubMed ID: 22699761
[TBL] [Abstract][Full Text] [Related]
8. The small molecule rhodomyrtone suppresses TNF-α and IL-17A-induced keratinocyte inflammatory responses: A potential new therapeutic for psoriasis.
Chorachoo J; Lambert S; Furnholm T; Roberts L; Reingold L; Auepemkiate S; Voravuthikunchai SP; Johnston A
PLoS One; 2018; 13(10):e0205340. PubMed ID: 30321197
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis.
Vandeghinste N; Klattig J; Jagerschmidt C; Lavazais S; Marsais F; Haas JD; Auberval M; Lauffer F; Moran T; Ongenaert M; Van Balen M; Dupont S; Lepescheux L; Garcia T; Härtle S; Eyerich K; Fallon PG; Brys R; Steidl S
J Invest Dermatol; 2018 Jul; 138(7):1555-1563. PubMed ID: 29474945
[TBL] [Abstract][Full Text] [Related]
10. Suppression of TCF4 promotes a ZC3H12A-mediated self-sustaining inflammatory feedback cycle involving IL-17RA/IL-17RE epidermal signaling.
Jiang Y; Gruszka D; Zeng C; Swindell WR; Gaskill C; Sorensen C; Brown W; Gangwar RS; Tsoi LC; Webster J; Sigurðardóttir SL; Sarkar MK; Uppala R; Kidder A; Xing X; Plazyo O; Xing E; Billi AC; Maverakis E; Kahlenberg JM; Gudjonsson JE; Ward NL
JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38470486
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients.
Swindell WR; Johnston A; Voorhees JJ; Elder JT; Gudjonsson JE
BMC Genomics; 2013 Aug; 14():527. PubMed ID: 23915137
[TBL] [Abstract][Full Text] [Related]
12. Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling.
Johnston A; Guzman AM; Swindell WR; Wang F; Kang S; Gudjonsson JE
Br J Dermatol; 2014 Jul; 171(1):97-107. PubMed ID: 24601997
[TBL] [Abstract][Full Text] [Related]
13. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
Mercurio L; Morelli M; Scarponi C; Eisenmesser EZ; Doti N; Pagnanelli G; Gubinelli E; Mazzanti C; Cavani A; Ruvo M; Dinarello CA; Albanesi C; Madonna S
Cell Death Dis; 2018 Oct; 9(11):1104. PubMed ID: 30377293
[TBL] [Abstract][Full Text] [Related]
14. IL-17C amplifies epithelial inflammation in human psoriasis and atopic eczema.
Lauffer F; Jargosch M; Baghin V; Krause L; Kempf W; Absmaier-Kijak M; Morelli M; Madonna S; Marsais F; Lepescheux L; Albanesi C; Müller NS; Theis FJ; Schmidt-Weber C; Eyerich S; Biedermann T; Vandeghinste N; Steidl S; Eyerich K
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):800-809. PubMed ID: 31793105
[TBL] [Abstract][Full Text] [Related]
15. TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques.
Gottlieb AB; Chamian F; Masud S; Cardinale I; Abello MV; Lowes MA; Chen F; Magliocco M; Krueger JG
J Immunol; 2005 Aug; 175(4):2721-9. PubMed ID: 16081850
[TBL] [Abstract][Full Text] [Related]
16. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept.
Caldarola G; De Simone C; Carbone A; Tulli A; Amerio P; Feliciani C
Int J Immunopathol Pharmacol; 2009; 22(4):961-6. PubMed ID: 20074459
[TBL] [Abstract][Full Text] [Related]
17. Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis.
Chen HL; Lo CH; Huang CC; Lu MP; Hu PY; Chen CS; Chueh DY; Chen P; Lin TN; Lo YH; Hsiao YP; Hsu DK; Liu FT
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33055419
[TBL] [Abstract][Full Text] [Related]
18. Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis.
Singh TP; Schön MP; Wallbrecht K; Gruber-Wackernagel A; Wang XJ; Wolf P
PLoS One; 2013; 8(1):e51752. PubMed ID: 23335955
[TBL] [Abstract][Full Text] [Related]
19. TNF-α and IL-17A induce the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
Sugihara S; Sugimoto S; Tachibana K; Kobashi M; Nomura H; Miyake T; Hirai Y; Yamasaki O; Morizane S
J Dermatol Sci; 2019 Oct; 96(1):26-32. PubMed ID: 31501002
[TBL] [Abstract][Full Text] [Related]
20. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
